Chongqing Zhifei Biological Products Co Ltd - Class A
SZSE:300122 (China)
Â
Class A
Â¥
67.45
(-0.78%)
Nov 28
Business Description
Chongqing Zhifei Biological Products Co Ltd
NAICS : 325414
ISIN : CNE100000V20
Share Class Description:
SZSE:300122: Class ACompare
Compare
Traded in other countries / regions
300122.China IPO Date
2010-09-28Description
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.67 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 0.44 | |||||
| Interest Coverage | 156.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.8 | |||||
| Beneish M-Score | -1.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 53.5 | |||||
| 3-Year EBITDA Growth Rate | 45.8 | |||||
| 3-Year EPS without NRI Growth Rate | 46.5 | |||||
| 3-Year FCF Growth Rate | -12.2 | |||||
| 3-Year Book Growth Rate | 61.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.17 | |||||
| 9-Day RSI | 74.92 | |||||
| 14-Day RSI | 71.9 | |||||
| 6-1 Month Momentum % | 29.78 | |||||
| 12-1 Month Momentum % | 4.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 99.11 | |||||
| Days Sales Outstanding | 172.99 | |||||
| Days Payable | 124.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.74 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 6.3 | |||||
| Forward Dividend Yield % | 0.74 | |||||
| 5-Year Yield-on-Cost % | 26.43 | |||||
| Shareholder Yield % | -0.17 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.64 | |||||
| Operating Margin % | 21.73 | |||||
| Net Margin % | 17.02 | |||||
| FCF Margin % | 4.98 | |||||
| ROE % | 32.43 | |||||
| ROA % | 19.72 | |||||
| ROIC % | 34.78 | |||||
| ROC (Joel Greenblatt) % | 40.4 | |||||
| ROCE % | 37.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.58 | |||||
| PE Ratio without NRI | 19.58 | |||||
| Shiller PE Ratio | 48.88 | |||||
| Price-to-Owner-Earnings | 21.57 | |||||
| PEG Ratio | 0.26 | |||||
| PS Ratio | 3.35 | |||||
| PB Ratio | 5.4 | |||||
| Price-to-Tangible-Book | 5.63 | |||||
| Price-to-Free-Cash-Flow | 64.16 | |||||
| Price-to-Operating-Cash-Flow | 44.97 | |||||
| EV-to-EBIT | 16.59 | |||||
| EV-to-EBITDA | 16.59 | |||||
| EV-to-Revenue | 3.31 | |||||
| EV-to-FCF | 62.96 | |||||
| Price-to-Projected-FCF | 3.01 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.72 | |||||
| Price-to-Graham-Number | 2.12 | |||||
| Price-to-Net-Current-Asset-Value | 7.11 | |||||
| Earnings Yield (Greenblatt) % | 6.03 | |||||
| FCF Yield % | 1.53 | |||||
| Forward Rate of Return (Yacktman) % | 21.55 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Zhifei Biological Products Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 49,712.442 | ||
| EPS (TTM) (Â¥) | 3.444 | ||
| Beta | 1.25 | ||
| Volatility % | 39.93 | ||
| 14-Day RSI | 71.9 | ||
| 14-Day ATR (Â¥) | 2.596837 | ||
| 20-Day SMA (Â¥) | 64.098 | ||
| 12-1 Month Momentum % | 4.76 | ||
| 52-Week Range (Â¥) | 41.56 - 70.824675 | ||
| Shares Outstanding (Mil) | 2,400 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chongqing Zhifei Biological Products Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chongqing Zhifei Biological Products Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chongqing Zhifei Biological Products Co Ltd Frequently Asked Questions
What is Chongqing Zhifei Biological Products Co Ltd(SZSE:300122)'s stock price today?
The current price of SZSE:300122 is ¥67.45. The 52 week high of SZSE:300122 is ¥70.82 and 52 week low is ¥41.56.
When is next earnings date of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122)?
The next earnings date of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is .
Does Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) pay dividends? If so, how much?
The Dividend Yield %  of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is 0.74% (As of Today), Highest Dividend Payout Ratio of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) was 2.46. The lowest was 0.03. And the median was 0.29. The  Forward Dividend Yield % of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is 0.74%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers